Is a pcsk9 inhibitor right for your patient? a review of treatment data for individualized therapy

HIGHLIGHTS

• who: Roman A. Beltran and colleagues from the DepartmentMidwestern University Glendale, AZ, USA have published the article: Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy, in the Journal: (JOURNAL)
• what: In this review, these options were explored, with a focus on PCSK9 inhibitors. The non-statin treatment that has become the focus of this literature review and treatment evaluation is PCSK-9 inhibitors. The primary findings of the study showed a significant association between baseline PCSK9 levels and 10-year progression of carotid atherosclerosis. At the start . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.